Mesogastrium Metastasis in Colon Cancer
Recruiting now
Conditions studied: Colon Cancer
In brief
Complete mesocolic excision is currently recognized as a standard procedure for colon cancer. Controversy remains on the presence of right gastroepiploic mesentery metastasis in patients with colon cancer locating at or close to the hepatic flexure. The investigators design this study in order to define the incidence of mesogastrium metastasis and analyse the safety and surgical outcome in these patients who undergo complete mesocolic excision with right gastroepiploic mesentery resection.
Key facts
- Study ID
- NCT04980287
- Run by
- Jichao Qin
- People needed
- 50
- Starts
- 2021-01-12
- Expected to finish
- 2026-07-19
- Last updated by the study team
- 2025-04-10
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age between 18 and 75 years
- American Society of Anesthesiologists (ASA) score I to III
- A biopsy proven histological diagnosis of colorectal carcinoma
- Preoperative staging cT2-4aN0M0 or cTanyN+M0
- tumor located at hepatic flexure or transverse colon close to flexures
- Undergoing complete mesocolic excision with right gastric mesentery resection
- Patients have to be aware of the aim of the trial, and have signed the informed consent.
You may not qualify if…
- Synchronous colorectal carcinoma
- Clinical evidence of metastasis
- History of colorectal cancer or other malignant tumors
- Preoperative staging cT1N0 or cT4bNany
- Emergency procedure
Where it is running
- Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology — Wuhan, Hubei, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.